Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Josef, VodiČka"'
Publikováno v:
Vnitřní lékařství. 68:217-220
Despite improvements in staging, surgical techniques, and the introduction of adjuvant chemotherapy for stage II and III nonsmall cell lung cancer (NSCLC), a large number of operated patients have recurrences of the disease. Due to the breakthrough r
Autor:
Josef Vodička, Jan Geiger, Alexandra Židková, Pavel Andrle, Hynek Mírka, Martin Svatonˇ, Tomáš Kostlivý
Publikováno v:
Annals of Thoracic and Cardiovascular Surgery. 28:171-179
The aims of this work were the retrospective analysis of a cohort of patients with acute mediastinitis treated at the authors' worksite over a 15-year period and the identification of factors that significantly affect the outcomes of the therapy.Duri
Autor:
Jakub Fichtl, Vladislav Třeška, Tomáš Skalický, Václav Liška, Josef Vodička, Petr Duras, Jakub Šebek, Kristýna Procházková
Publikováno v:
Onkologie. 14:287-290
Autor:
Josef Vodička
Publikováno v:
Turkish Journal of Trauma and Emergency Surgery.
Autor:
KristÝna, ProchÁzkovÁ, KristÝna, PivovarČÍkovÁ, Milena, RouŠarovÁ, Josef, VodiČka, Petr, HoŠek, Inka, TŘeŠkovÁ, OndŘej, Hes, Radek, KuČera, OndŘej, TopolČan, Vladislav, TŘeŠka
Publikováno v:
In Vivo
Background/Aim: The aim of this study was to determine the importance of surgical treatment, utility of hormone receptor status and selected biomarkers in the prognosis of patients with liver metastases from breast cancer (BCLM). Patients and Methods
Publikováno v:
Prague Economic Papers. 17:340-355
This paper introduces a model for stress testing of probability of default of individuals. The model rests on assumption that the individual defaults if his savings fall below zero. The probability of default is then described as a function of severa
Autor:
Jakub, Fichtl, Vladislav, Treska, Daniel, Lysak, Hynek, Mirka, Petr, Duras, Marie, Karlikova, Tomas, Skalicky, Josef, Vodička, Ondrej, Topolcan
Publikováno v:
Anticancer research. 36(4)
Liver metastases occur in 60-80% of patients with colorectal carcinoma. The only potentially curative method is surgical resection, with an operability of 20-25%. The main reason for such low resectability is insufficient future liver remnant volume
Publikováno v:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie; 2018, Vol. 31 Issue 5, p376-379, 4p
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9721ce0578168a1140d03094d55dc97d
http://www.scopus.com/inward/record.url?eid=2-s2.0-85041716237&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85041716237&partnerID=MN8TOARS
Autor:
Josef Vodička, Špidlen, V., Šimánek, V., Šafránek, J., Fichtl, J., Mukenšnabl, P., Fínek, J., Roušarova, M.
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::43577dff282a0d2be44d8a13202e94fa
http://www.scopus.com/inward/record.url?eid=2-s2.0-80052234769&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-80052234769&partnerID=MN8TOARS